Mackenzie Financial’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-5,422
| Closed | -$277K | – | 1703 |
|
2024
Q4 | $277K | Buy |
5,422
+440
| +9% | +$22.5K | ﹤0.01% | 1418 |
|
2024
Q3 | $255K | Buy |
+4,982
| New | +$255K | ﹤0.01% | 1263 |
|
2023
Q3 | – | Sell |
-14,909
| Closed | -$269K | – | 1494 |
|
2023
Q2 | $269K | Buy |
+14,909
| New | +$269K | ﹤0.01% | 1206 |
|